Epilepsy

2021 Epilepsy Therapeutics Market SWOT Analysis, Competitive Landscape and Significant Growth

Reports Globe’s new report on Global Epilepsy Therapeutics Market provides in-depth coverage of industry and significant market trends with historical and forecast market information, demand, application information, price trends and shares of the leading Epilepsy Therapeutics Company by geography. This report also studies the Epilepsy Therapeutics market share, competitive landscape, …

Read More »

The Jordan Elizabeth Harris Foundation funds Cook Children research

The Jordan Elizabeth Harris Foundation, a non-profit organization providing suicide prevention education and training in North Texas, provided research funding in the amount of $ 49,950 to Dr. Crystal Cooper , a researcher at the Cook Children’s Jane and the John Justin Neuroscience Center. The study is titled: Cognitive biomarkers …

Read More »

Drug giants accused of charging NHS ‘unfairly high’ prices

D Carpet companies Pfizer and Flynn have been accused by the UK competition watchdog of abusing their dominant position to overcharge the NHS for anti-epileptic drugs in “overnight” skyrocketing prices. The Competition and Markets Authority (CMA) said it had provisionally found that Flynn and Covid-19 vaccine maker Pfizer violated competition …

Read More »

Development of a reverse optogenetic tool – ScienceDaily

A new optogenetic tool, a light-controllable protein, has been characterized by researchers at the Ruhr-Universität Bochum (RUB). They used an opsin – a protein found in the brain and eyes – from zebrafish and introduced it into the brains of mice. Unlike other optogenetic tools, this opsin is not turned …

Read More »

Zogenix product FINTEPLA® (Fenfluramine) Recognized for

In Epilepsy and behavior editorial, the authors write that the FINTEPLA data demonstrate “an unprecedented level of seizure control” for treated patients living with Dravet syndrome, a severe and debilitating epilepsy of childhood. The authors also recognize FINTEPLA for obtaining clinically important results in outcomes reported by caregivers, such as …

Read More »

Neuropeptide Y Receptor Type 2 (NPY Y2 Receptor or NPY2R) Drugs In Development, Research report 2021 with CombiGene, Gila Therapeutics, Takeda Pharmaceutical, XL-protein – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL THREAD)–The “Neuropeptide Y type 2 receptor (NPY Y2 or NPY2R receptor) – Drugs in development, 2021” drug pipelines was added to ResearchAndMarkets.com offer. Neuropeptide Y Receptor Type 2 pipeline (NPY Y2 Receptor or NPY2R) The target constitutes nearly 5 molecules. Neuropeptide Y type 2 receptor (NPY Y2 …

Read More »